No validated dosing, pharmacokinetics, or long-term safety There is no human pharmacokinetic data for injectable BPC-157: How long it lasts in the body What tissues it reaches Whether it accumulates How it is metabolized or excreted Long-term risks cannot be assessed without such information
However, given some of my dysmorphia and general anxiety surrounding weight/weight loss/eating, I yo-yo between happy with my weight loss and super sad
A beneficial human NAD effect has not been demonstrated
Migraine is the most common neurovascular disorder, and several hypotheses have been proposed for the pathogenesis of migraine
Liang MY, Zhang MJ, Qiu W, Xiao Y, Ye MJ, Xue P, Kang YJ
00:06:04 Vickie Danaher Okay, so now that weve cleared up the formulation issue, lets talk about how well orforglipron actually works for obesity